Evaluating the feasibility and effectiveness of chronic deep brain stimulation of the feeding center, ventromedial hypothalamus (VHM) of obese rats to effect weight loss. 2003 NeuroGrant Recipient
Evaluating the feasibility and effectiveness of chronic deep brain stimulation to the lateral hypothalamus of obese rats to effect weight loss.
Investigating the possibility of direct brain-to-speech activity in locked-in patients. 2004 NeuroGrant Recipient
To determine if bilateral deep brain stimulation of the Lateral Hypothalamus will lead to significant and sustained weight loss in primates. 2004 NeuroGrant Recipient
Training program for providers and the community to increase awareness and improve treatment for patients suffering from trigeminal neuralgia. 2005 NeuroGrant Recipient
Prospective longitudinal study to assess the impact of deep brain stimulation on behavior and mood in patients with idiopathic Parkinson’s Disease. 2005 NeuroGrant Recipient
Assessing the safety and efficacy of bilateral deep brain stimulation of the Globus Pallidus Internus in medically refractory dystonia. 2003 NeuroGrant Recipient
To determine the impact of unilateral deep brain stimulation of the Sub-Thalamic Nucleus (STN) on self reported quality of life measures and perceived caregiver burden in patients with advanced Parkinson’s disease and their families. 2004 NeuroGrant Recipient
Evaluating the immunological potential for the rejection of stem cell grafts in the treatment of MPTP-induced Parkinson-like symptoms. 2005 NeuroGrant Recipient
Elucidating the pathophysiology of patients with unusual diseases undergoing deep brain stimulation through the analysis of firing patterns. 2005 NeuroGrant Recipient
To determine the viability and potential for human hematopoietic stem cells either in their heterogeneous form or directed toward a DA phenotype, to repair, replace, or regenerate the loss of DA in the striatum in rats pre-treated with a DA neurotoxin. 2007 NeuroGrant Recipient
To elucidate the molecular mechanisms underlying the effect at early onset Familial Alzheimer's Disease (FAD)-linked Presenilin 1 on adult neurogenesis. 2008 NeuroGrant Recipient
“The CINN Associates strive to assist CINN in improving the lives of individuals with neurologic disorders such as stroke, brain tumors, epilepsy, Parkinson's disease, spinal cord injury and other back problems.”
For more information on how to become a CINN Associate or to speak with an Associate, please contact The CINN Foundation at 773/250.0300 or